Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease

Brain

Volumn 129, Issue 5, 2006, Pages 1137-1151

  Finke, Kathrin ^a   Bublak, Peter ^a,b   Dose, Matthias ^c   Müller, Hermann J ^a   Schneider, Werner X ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c Huntington Center South   (Germany)

Author keywords

Cognition; Huntington's disease; Neuropsychological markers; Spatial extinction; Visual attention

Indexed keywords

ADENINE; BIOLOGICAL MARKER; CYTOSINE; GUANINE;

ADULT; ARTICLE; ATTENTION DISTURBANCE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN REGION; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE; HUMAN; HUNTINGTON CHOREA; ITI5 GENE; MALE; NERVE DEGENERATION; NEUROANATOMY; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TASK PERFORMANCE; THALAMUS; THEORETICAL STUDY; VISUAL MEMORY; WORKING MEMORY;

ADULT; AGE OF ONSET; ATTENTION; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PERCEPTUAL DISORDERS; PHOTIC STIMULATION; REACTION TIME; SPACE PERCEPTION; TRINUCLEOTIDE REPEATS;

EID: 33646252482     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl040     Document Type: Article

References (88)

1. Alexander GE, De Long MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-81.
2. Andrews TC, Brooks DJ. Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET. Mol Med Today 1998; 4: 532-9.
3. Apicella P, Legallet E, Nieoullon A, Trouche E. Neglect of contralateral visual stimuli in monkeys with unilateral striatal dopamine depletion. Behav Brain Res 1991; 116: 456-66.
4. Aylward EH, Anderson NB, Bylsma FW, Wagster MV, Barta PE, Sherr M, et al. Frontal lobe volume in patients with Huntington's disease. Neurology 1998; 50: 252-8.
5. Aylward EH, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, et al. Onset and rate of striatal atrophy in preclinical Huntington's disease. Neurology 2004; 63: 66-72.
6. Balint R. Seelenlähmung des Schauens, optische Ataxie, räumliche Störung der Aufmerksamkeit. Monatsschr Psychiatr Neurol 1909; 25: 5-81.
7. Behrmann M, Geng JJ, Shomstein S. Parietal cortex and attention. Curr Opin Neurobiol 2004; 14: 212-7.
8. Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, et al. Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol 2005; 252: 36-41.
9. Brandt J. Cognitive impairments in Huntington's disease: insights into the neuropsychology of the striatum. In: Boller F, Grafman J, editors. Handbook of neuropsychology, 5th edn. Amsterdam: Elsevier; 1991. p. 241-64.
10. Brandt J, Butters N. The neuropsychology of Huntington's disease. Trends Neurosci 1986; 9: 118-20.
11. Brodie EE, Dunn EM. Visual line bisection in sinistrals and dextrals as a function of hemispace, hand, and scan direction. Brain Cogn 2005; 58: 149-56.
12. Brown RG, Marsden CD. Subcortical dementia: the neuropsychological evidence. Neuroscience 1988, 25: 363-87.
13. Bublak P, Finke K, Krummenacher J, Preger R, Kyllingsbaek S, Müller HJ, et al. Usability of a theory of visual attention (TVA) for parameter-based measurement of attention II: Evidence from two patients with frontal or parietal damage. J Int Neuropsychol Soc 2005, 11: 843-54.
14. Bundesen C. A theory of visual attention. Psychol Rev 1990; 97: 523-47.
15. Bundesen C. A computational theory of visual attention. Philos Trans R Soc Lond B Biol Sci 1998; 353: 1271-81.
16. Bundesen C. A general theory of visual attention. In: Bäckman L, von Hofsten C, editors. Psychology at the turn of the millennium. Cognitive, biological, and health perspectives, Vol. 1. Hove: Psychology Press; 2002. p. 179-200.
17. Bundesen C, Habekost T, Kyllingsbæk S. A neural theory of visual attention: bridging cognition and neurophysiology. Psychol Rev 2005; 112: 291-328.
18. Chow TW, Cummings JL. Frontal-subcortical circuits. In: Miller BL, Cummings JL, editors. The human frontal lobes. New York: Guilford Press; 1999. p. 3-26.
19. Coslett HB, Saffran E. To see but not two see. Brain 1991; 114: 1523-45.
20. Damasio AR, Damasio H, Chui HC. Neglect following damage to frontal lobe or basal ganglia. Neuropsychologia 1980; 18: 123-32.
21. Desimone R, Duncan J. Neural mechanisms of selective visual attention. Annu Rev Neurosci 1995; 18: 193-222.
22. Driver J Vuilleumier P. Perceptual awareness and its loss in unilateral neglect and extinction. Cognition 2001; 79: 39-88.
23. Duncan J. Cooperating brain systems in selective perception and action. In: Inui T, McClelland JL, editors. Attention and performance XVI. Cambridge (MA): MIT Press; 1996. p. 549-78.
24. Duncan J, Bundesen C, Olson A, Humphreys G, Chavda S, Shibuya H. Systematic analysis of deficits in visual attention. J Exp Psychol Gen 1999; 128: 450-78.
25. Duncan J, Bundesen C, Olson A, Humphreys G, Ward R, Kyllingsbæk S, et al. Attentional functions in dorsal and ventral simultanagnosia. Cogn Neuropsychol 2003; 20: 675-701.
26. Duncan J, Humphreys G, Ward R. Competitive brain activity in visual attention. Curr Opin Neurobiol 1997; 7: 255-61.
27. Fielding J, Georgiou-Karistianis N, Millist L, White O. Temporal variation in the control of goal-directed visuospatial attention in basal ganglia disorders. J Neurosci Res 2006; 54: 57-64.
28. Filoteo JV, Delis DC, Roman MJ, Demadura T, Ford E, Butters N, et al. Visual attention and perception in patients with Huntington's disease: comparisons with other subcortical and cortical dementias. J Clin Exp Neuropsychol 1995; 17: 654-67.
29. Fimm B, Zahn R, Mull M, Kemeny S, Buchwald F, Block F, et al. Asymmetries of visual attention after circumscribed subcortical vascular lesions. J Neurol Neurosurg Psychiatry 2001; 71: 652-7.
30. Finke K, Bublak P, Krummenacher J, Kyllingsbæk S, Müller HJ, Schneider WX. Usability of a theory of visual attention (TVA) for parameter-based measurement of attention I: Evidence from normal subjects. J Int Neuropsychol Soc 2005; 11: 832-42.
31. Furtado S, Suchowersky O, Rewcastle NB, Graham L, Klimek ML, Garber A. Relationship between trinucleotide repeat and neuropathological changes in Huntington's disease. Ann Neurol 1996; 41: 689-92.
32. Georgiou N, Bradshaw JL, Phillips JG, Bradshaw JA, Chiu E. The Simon effect and attention deficits in Gilles de la Tourette's syndrome and Huntington's disease. Brain 1995; 118: 1305-18.
33. Georgiou N, Bradshaw JL, Phillips JG, Chiu E. The effect of Huntington's disease and Gilles de la Tourette's syndrome on the ability to hold and shift attention. Neuropsychologia 1996; 34: 843-51.
34. Georgiou N, Bradshaw JL, Phillips JG, Chiu E. Effect of directed attention in Huntington's disease. J Clin Exp Neuropsychol 1997; 19: 367-77.
35. Gomez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, Weiler LJ, Cupples LA, et al. Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol 2001; 49: 29-34.
36. Gusella JF, MacDonald ME. Huntington's disease. Semin Cell Biol 1995; 6: 21-8.
37. Habekost T, Bundesen C. Patient assessment based on a theory of visual attention (TVA): subtle deficits after a right frontal-subcortical lesion, Neuropsychologia 2003; 41: 1171-88.
38. Habekost T, Rostrup E. Persisting asymmetries of vision after right side lesions. Neuropsychologia 2006; in press.
39. Hamilton JM, Haaland KY, Adair JC, Brandt J. Ideomotor limb apraxia in Huntington's disease: implications for corticostriate involvement. Neuropsychologia 2003; 41: 614-21.
40. Harper PS. Huntington's disease. Major problems in neurology, Vol. 22. London: Saunders; 1991.
41. Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 2000; 80: 953-78.
42. Ho AK, Manly T, Nestor PJ, Sahakian BJ, Bak TH, Robbins TW, et al. A case of unilateral neglect in Huntington's disease. Neurocase 2003a; 9: 261-73.
43. Ho AK, Nestor PJ, Williams GB, Bradshaw JL, Sahakian BJ, Robbins TW, et al. Pseudo-neglect in Huntington's disease correlates with decreased angular gyrus density. Neuroreport 2004; 15: 1061-4.
44. Ho AK, Sahakian BJ, Brown RG, Barker RA, Hodges JR, Ané MN, et al. Profile of cognitive progression in early Huntington's disease. Neurology 2003b; 61: 1702-6.
45. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-83.
46. Jahanshahi M, Brown RG, Marsden CD. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease. J Neurol Neurosurg Psychiatry 1993; 56: 1169-77.
47. Jewell G, McCourt ME. Pseudoneglect: a review and meta-analysis of performance factors in line bisection tasks. Neuropsychologia 2000; 38: 93-110.
48. Kanwisher N, Wojciulik E. Visual attention: insights from brain imaging. Nat Rev Neurosci 2000; 1: 91-100.
49. Karnath H-O, Himmelbach M, Rorden C. The subcortical anatomy of human spatial neglect: putamen, caudate nucleus and pulvinar. Brain 2002; 125: 350-60.
50. Kastner S, Ungerleider LG. Mechanisms of visual attention in the human cortex. Annu Rev Neurosci 2000; 23: 315-41.
51. Kato M, Miyashita N, Hikosaka O, Matsumura M, Usui S, Kori A. Eye movements in monkeys with local dopamine depletion in the caudate nucleus. I. Deficits in spontaneous saccades. J Neurosci 1995; 15: 912-27.
52. Kipps CM, Duggins AJ, Mahant N, Gomes L, Ashburner J, McCusker EA. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J Neurol Neurosurg Psychiatry 2005; 75: 650-5.
53. Kyllingsbæk S. Modeling visual attention. Behav Res Methods 2006; in press.
54. Lawrence AD, Hodges JR, Rosser AE, Kershaw A, French-Constant C, Rubinstein DC, et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 1998; 121: 1329-41.
55. Lawrence AD, Watkins LH, Sahakian BJ, Hodges JR, Robbins TW. Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain 2000; 123: 1349-64.
56. Luh KE. Line bisection and perceptual asymmetries in normal individuals: what you see is not what you get. Neuropsychology 1995; 9: 435-48.
57. Marzi CA, Girelli M, Natale E, Miniussi C. What exactly is extinguished in unilateral visual extinction? Neurophysiological evidence. Neuropsychologia 2001; 39: 1354-66.
58. Mattingley, JB, Berberovic N, Corben L, Slavin MJ, Nicholls MER, Bradshaw JL. The greyscales task: a perceptual measure of attentional bias following unilateral hemispheric damage. Neuropsychologia 2004; 42: 387-94.
59. Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioural, and clinical studies. Brain Cogn 2000; 42: 183-200.
60. Milner AD. Neglect, extinction, and the cortical streams of visual processing. In: Karnath HO, Thier P, editors. Parietal lobe contributions to orientation in 3D space. Berlin: Springer; 1997. p. 3-22.
61. Miyashita N, Hikosaka O, Kato M. Visual hemineglect induced by unilateral striatal dopamine deficiency in monkeys. Neuroreport 1995; 6: 1257-60.
62. Müller SV, Jung A, Preinfalk J, Kolbe H, Ridao-Alonso M, Dengler R, et al. Disturbance of "extrinsic alertness" in Huntington's disease. J Clin Exp Neuropsychol 2002; 24: 517-26.
63. Oldfield R. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9: 97-113.
64. Paulsen JS, Zhao H, Stout JC, Brinkman RR, Guttman M, Ross CA, et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology 2001; 57: 658-62.
65. Paulsen JS, Magnotta VA, Milos AE, Paulson HL, Penziner E, Andreasen NC, et al. Brain structure in preclinical Huntington's disease. Biol Psychiatry 2006; 29: 57-63.
66. Paulsen JS, Zimbelman JL, Hinton SC, Langbehn DR, Leveroni CL, Benjamin ML, et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. Am J Neuroradiol 2004; 25: 1715-21.
67. Penney JB, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997; 41: 689-92.
68. Peers PV, Ludwig CJH, Rorden C, Cusack R, Bonfiglioli C, Bundesen C, et al. Attentional functions of parietal and frontal cortex. Cereb Cortex 2005; 15: 1469-84.
69. Reynolds JH, Desimone R. Interacting roles of attention and visual salience in V4. Neuron 2003; 37: 853-63.
70. Rijcken CAW, Monster TBM, Brouwers JRBJ, de Jong-van den Berg LTW. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses? J Clin Psychopharmacol 2003; 23: 657-9.
71. Roman MJ, Delis DC, Filoteo JV, Demadura T, Paulsen J, Swerdlow NR, et al. Is there a 'subcortical' profile of attentional dysfunction? A comparison of patients with Huntington's and Parkinson's diseases on a global-local focused attention task. J Clin Exp Neuropsychol 1998; 20: 873-84.
72. Rosas HD, Goodman J, Chen YI, Jenkins BG, Kennedy DN, Makris N, et al. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. Neurology 2001; 57: 1025-8.
73. Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002; 58: 695-701.
74. Rosas HD, Hevelone ND, Zaleta AK, Greve DN, Salat DH, Fischl B. Regional cortical thinning in preclinical Huntington's disease and its relationship to cognition. Neurology 2005; 65: 745-7.
75. Ross SM. Introduction to probability and statistics for engineers and scientists. San Diego (CA): Academic Press; 2000.
76. Sakashita Y. Visual attentional disturbance with unilateral lesions in the basal ganglia and deep white matter. Ann Neurol 1991; 30: 673-77.
77. Schneider, WXS. VAM: a neuro-cognitive model for visual attention control of segmentation, object recognition, and space-based motor action. Vis Cogn 1995; 2: 331-75.
78. Sperling G. The information available in brief visual presentations. Psychol Monogr 1960; 74: 11.
79. Sprengelmeyer R, Lange H, Hömberg V. The pattern of attentional deficits in Huntington's disease. Brain 1995; 118: 145-52.
80. Stone SP, Halligan PW, Greenwood RJ. The incidence of neglect phenomena and related disorders in patients with an acute right or left hemisphere stroke. Age Ageing 1993; 22: 46-52.
81. Thieben MJ, Duggins AJ, Good CD, Gomes L, Mahant N, Richards F, et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002; 125: 1815-28.
82. Tost H, Wendt CS, Schmitt A, Heinz A, Braus DF. Huntington's disease: Phenomenological diversity of a neuropsychiatric condition that challenges traditional concepts in neurology and psychiatry. Am J Psychiatry 2004; 161: 28-34.
83. Tsai TT, Lasker A, Zee DS. Visual attention in Huntington's disease: the effect of cuing on saccade latencies and manual reaction times. Neuropsychologia 1995; 33: 1617-26.
84. Vallar G, Rusconi ML, Bignamini L, Geminiani G, Perani D. Anatomical correlates of visual and tactile extinction in humans: a clinical CT scan study. J Neurol Neurosurg Psychiatry 1994; 57: 464-70.
85. Villardita C, Smirni P, Zappalà G. Visual neglect in Parkinson's disease. Arch Neurol 1983; 40: 737-9.
86. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559-77.
87. Watkins LHA, Rogers RD, Lawrence AD, Sahakian BJ, Rosser AE, Robins TW. Impaired planning but intact decision making in early Huntington's disease: implications for specific fronto-striatal pathology. Neuropsychologia 2000; 38: 1112-25.
88. Wolpert I. Die Simultanagnosie. Z Gesamte Neurol Psychiat 1924; 93: 397-415.